Effect of tumor necrosis factor-alpha blocker (infliximab) on blastocyst development in vitro

Javier Noriega, Mohamed A. Bedaiwy, Mohamed Bedaiwy, Rakesh Sharma, Tommaso Falcone
Fertility and sterility · 2004 · vol. 81(6) , pp. 1704–1706 · doi:10.1016/j.fertnstert.2003.12.019 · PMID:15193503 · W1984867476
Lab / animal OA: bronze CC0 ⤵ 2 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This study investigated the impact of infliximab, a tumor necrosis factor-α blocker, on blastocyst development in vitro.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Infliximab does not have any toxic effects on early cleaving embryos.

My notes (saved in your browser only)

MeSH descriptors

Antibodies, Monoclonal Blastocyst Blastocyst Tumor Necrosis Factor-alpha Antibodies, Monoclonal Blastocyst Embryonic and Fetal Development Humans Infliximab In Vitro Techniques Tumor Necrosis Factor-alpha

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (9)

Cited by (2)

SciLite annotations

chemicals 2
etanercept etanercept

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:02:35.474120+00:00
scilite
last seen: 2026-05-18T04:25:29.313245+00:00
License: CC0 · commercial use OK